Evidence against in utero transmission of hepatitis B virus

被引:0
作者
Yi-Hua Zhou
机构
[1] Nanjing University Medical School,Departments of Laboratory Medicine and Infectious Diseases, Nanjing Drum Tower Hospital and Jiangsu Key Laboratory for Molecular Medicine
来源
Nature Reviews Gastroenterology & Hepatology | 2021年 / 18卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:445 / 445
相关论文
共 9 条
[1]  
Terrault NA(2021)Viral hepatitis and pregnancy Nat. Rev. Gastroenterol. Hepatol. 18 117-130
[2]  
Cheung KW(2018)Immunoprophylaxis Failure of Infants Born to Hepatitis B Carrier Mothers Following Routine Vaccination Clin. Gastroenterol. Hepatol. 16 144-145
[3]  
Wen WH(2016)Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection Hepatology 64 1451-1461
[4]  
Huang H(2020)Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus Clin. Infect. Dis. 378 911-923
[5]  
Jourdain G(2018)Tenofovir versus placebo to prevent perinatal transmission of hepatitis B N. Engl. J. Med. 25 429-437
[6]  
Hu Y(2018)Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: A multicenter prospective cohort study J. Viral. Hepat. 270 287-291
[7]  
Schweitzer IL(1975)Vertical transmission of the hepatitis B surface antigen Am. J. Med. Sci. 2 1103-1104
[8]  
Goudeau A(1983)Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection Lancet 51 864-869
[9]  
Liu J(2019)Presence of hepatitis B virus markers in umbilical cord blood: exposure to or infection with the virus? Dig. Liver Dis. 67 370-398